aTyr Pharma Inc. (ATYR)

AI Score

Unlock

2.62

-0.17 (-6.09%)

At close: Apr 04, 2025, 3:59 PM

2.61

-0.07%

After-hours: Apr 04, 2025, 05:58 PM EDT

aTyr Pharma Balance Sheet Statement

Chart Mode

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Cash & Equivalents	11.05M	22.54M	9.98M	2.34M	16.95M	9.21M	22.96M	21.09M	38.39M	53.02M	13.9M	36.46M	3.67M
Short-Term Investments	61.07M	75.62M	56.16M	105.58M	14.74M	21.93M	26.58M	64.03M	33.76M	42.51M	1.95M	n/a	n/a
Long-Term Investments	n/a	3.48M	3.17M	n/a	n/a	n/a	n/a	n/a	4M	29.81M	n/a	n/a	69K
Other Long-Term Assets	3.02M	131K	193K	158K	213K	172K	90K	90K	333K	118K	2.21M	260K	331K
Receivables	1.74M	2.44M	11.78M	435K	2.04M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	816K
Total Current Assets	81.95M	102.99M	80.87M	113.57M	35.53M	31.93M	50.8M	86.98M	74.77M	97.95M	16.51M	37.02M	4.49M
Property-Plant & Equipment	11.86M	14.05M	11.56M	1.81M	2.98M	4.09M	1.85M	2.28M	1.42M	1.79M	1.93M	2.5M	2.58M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	14.88M	17.66M	14.91M	1.97M	3.19M	4.26M	1.94M	2.37M	5.76M	31.73M	4.13M	2.77M	2.98M
Total Assets	96.83M	120.65M	95.79M	115.54M	38.73M	36.19M	52.75M	89.36M	80.52M	129.68M	20.64M	39.79M	7.47M
Account Payables	4.32M	3.53M	3.11M	1.03M	1.43M	847K	1.04M	2.28M	2.61M	3.87M	1.43M	1.05M	593K
Deferred Revenue	n/a	n/a	n/a	1.00	n/a	208K	n/a	n/a	130K	n/a	n/a	n/a	255K
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	8.74M	7.77M	5.01M	339K	3.37M	5.13M	728K	875K
Other Current Liabilities	n/a	n/a	n/a	n/a	n/a	2.2M	n/a	n/a	3.6M	315K	614K	2.02M	444K
Total Current Liabilities	14.97M	16.42M	13.86M	6.01M	5.86M	12.92M	10.83M	10.39M	8.53M	12.15M	10.11M	5.21M	3.53M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	8.26M	14.72M	9.2M	1.78M	5.14M	6.16M	3.67M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	701K	96.4M	94.5M	512K
Total Long-Term Liabilities	12.03M	13.77M	10.64M	398K	1.38M	2.24M	8.26M	14.72M	9.2M	2.48M	101.54M	100.66M	5.2M
Total Liabilities	27M	30.18M	24.5M	6.41M	7.24M	15.16M	19.1M	25.11M	17.72M	14.63M	111.65M	105.87M	8.73M
Total Debt	13.28M	15.1M	11.53M	1.38M	2.24M	11.73M	16.03M	19.73M	9.54M	5.14M	10.28M	6.89M	4.54M
Common Stock	84K	63K	29K	28K	11K	4K	31K	30K	24K	24K	1K	1K	6K
Retained Earnings	-532.05M	-468.02M	-417.63M	-372.3M	-338.53M	-322.3M	-298.7M	-264.19M	-215.98M	-158.12M	-110.15M	-85.8M	-64.52M
Comprehensive Income	-40K	-74K	-433K	-263K	-43K	-40K	-60K	-120K	-76K	-171K	-69K	-69K	n/a
Shareholders Equity	70.02M	90.66M	71.46M	109.3M	31.65M	21.19M	33.65M	64.25M	62.8M	115.05M	-91.01M	-68.5M	-1.28M
Total Investments	61.07M	79.11M	59.33M	105.58M	14.74M	21.93M	26.58M	64.03M	37.76M	72.32M	1.95M	n/a	69K